Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Non-comparative Study to Evaluate the Efficacy and Safety of AUGMENTIN 1gm (875mg Amoxicillin/125mg Clavulanic Acid) po q 12 Hours in the Treatment of Uncomplicated Skin and Soft Tissue Infections in Pakistan

NCT00343135 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00343135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00343135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Non-comparative Study to Evaluate the Efficacy and Safety of AUGMENTIN 1gm (875mg Amoxicillin/125mg Clavulanic Acid) po q 12 Hours in the Treatment of Uncomplicated Skin and Soft Tissue Infections in Pakistan
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2004
Completion date
March 31, 2005
Enrollment
195 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

infection, soft tissue, skin diseases, infectious